NK3 Homeobox 1 (NKX3-1) (Middle Region) Peptide
NKX3-1
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all NKX3-1 products
- NKX3-1 (NK3 Homeobox 1 (NKX3-1))
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- HLAKNLKLTE TQVKIWFQNR RYKTKRKQLS SELGDLEKHS SLPALKEEAF
- Characteristics
- This is a synthetic peptide designed for use in combination with anti- NKX3-1 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- NKX3-1 (NK3 Homeobox 1 (NKX3-1))
- Synonyms
- Xbagpipe Peptide, Xbap Peptide, bagpipe Peptide, koza Peptide, nkx3-1 Peptide, nkx3.1 Peptide, si:ch211-67o1.2 Peptide, nkx3a Peptide, MGC53041 Peptide, MGC97890 Peptide, Bax Peptide, NKX3.1 Peptide, NKX3A Peptide, Nkx-3.1 Peptide, BAPX2 Peptide, NKX3 Peptide, NK3 homeobox 1 L homeolog Peptide, NK3 homeobox 1 Peptide, NK-3 transcription factor, locus 1 (Drosophila) Peptide, nkx3-1.L Peptide, NKX3-1 Peptide, nkx3-1 Peptide, Nkx3-1 Peptide
- Background
-
This gene encodes a homeobox-containing transcription factor. This transcription factor functions as a negative regulator of epithelial cell growth in prostate tissue. Aberrant expression of this gene is associated with prostate tumor progression. Alternate splicing results in multiple transcript variants of this gene.
Alias Symbols: NKX3, BAPX2, NKX3A, NKX3.1
Protein Size: 234 - Gene ID
- 4824
- NCBI Accession
- NM_001256339, NP_001243268
- UniProt
- Q99801
-
You are here:
